Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Angong Jiangyawan
- Development stage
- Unknown
- Lead developer
- Beijing Tong Ren Tang
- Administration
- Oral
01
Overview
Angong Jiangyawan is a Traditional Chinese Medicine (TCM) formula developed and manufactured by Beijing Tongrentang, specifically indicated for the treatment of hypertension and associated symptoms such as dizziness, headache, and insomnia. The formulation is designed to clear heat, calm the liver, and extinguish wind, addressing the TCM pattern of hyperactivity of liver-yang. It contains a complex mixture of ingredients including Margarita (pearl), Cornu Bubali (water buffalo horn), and various herbal extracts like Scutellariae Radix and Coptidis Rhizoma. Clinical research, including trials registered in the Chinese Clinical Trial Registry (ChiCTR), has explored its efficacy in both primary and secondary hypertension, often evaluating its role in blood pressure variability and long-term safety.
- Brand names
- Angong Jiangyawan
- Other names
- Angong Jiangya Pill安宫降压丸
02
Targets
IL-6 (Interleukin 6)PIK3CA (Phosphoinositide 3-kinase alpha)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)MAPK3 (Mitogen-activated protein kinase 1)
Beyond the preview
Go deeper on Angong Jiangyawan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Angong Jiangyawan.